🇺🇸 FDA
Patent

US 7879334

Fusion molecules and treatment of IgE-mediated allergic diseases

granted A61KA61K2039/505A61P

Quick answer

US patent 7879334 (Fusion molecules and treatment of IgE-mediated allergic diseases) held by The Regents of the University of California expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61P, A61P1/04, A61P1/08